Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates

Simon J Stanworth1

  • 1National Health Service (NHS) Blood & Transplant/Oxford University Hospitals NHS Trust, Oxford, United Kingdom. simon.stanworth@nhsbt.nhs.uk

Insights

Platelet transfusions are common for premature infants with low platelet counts, but evidence supporting their prophylactic use is lacking. More research is needed to establish safe and effective transfusion guidelines for neonates.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Critical Care

Background:

  • Premature infant survival has improved with supportive care, including red blood cell (RBC) transfusions.
  • Neonatal thrombocytopenia is frequent in premature infants, linked to intrauterine growth restriction, maternal hypertension, sepsis, or necrotizing enterocolitis.
  • The role and efficacy of platelet transfusions in neonates remain controversial, with no clear link established between platelet count and major hemorrhage risk.

Purpose of the Study:

  • To evaluate the current practices and evidence base for prophylactic platelet transfusions in premature neonates.
  • To highlight the lack of clinical trials defining optimal pretransfusion platelet count thresholds.
  • To underscore the need for randomized controlled trials to guide safe and effective platelet transfusion practices in this population.

Main Methods:

  • Review of existing literature on neonatal thrombocytopenia and platelet transfusion practices.
  • Analysis of current variations in pretransfusion platelet count thresholds across institutions and countries.
  • Identification of the absence of recent clinical trials comparing different transfusion thresholds in premature neonates.

Main Results:

  • Significant variation exists in platelet transfusion practices and pretransfusion thresholds among hospitals and countries.
  • There is a lack of robust clinical trial evidence to support the common prophylactic use of platelet transfusions in premature neonates.
  • Cardiorespiratory problems, not platelet count, are primary factors in neonatal intraventricular/periventricular hemorrhage.

Conclusions:

  • Current prophylactic platelet transfusion practices in premature neonates lack a strong evidence base.
  • Widespread disparities in transfusion thresholds indicate a need for standardized guidelines.
  • Randomized controlled trials are essential to determine optimal platelet transfusion strategies for premature infants, given their heavy current use.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...